Ravindra Gupta, Distinguished Professor of Microbiology and Infectious Diseases at the University of Cambridge, shared his insights into the potential of stem cells at the Helen Clinic.

In a special interview, Mr. Gupta spoke about the challenges and opportunities associated with culturing large quantities of MSCs (mesenchymal stem cells), emphasizing the importance of maintaining purity and remaining vigilant throughout the process. He praised Hellene Clinic's efforts to achieve the culture of 2.25 billion MSCs, particularly the multilayer culture flasks, specialized "Helene Growth Medium" and strict quality to ensure pure MSCs reach patients. Emphasis was placed on a combination of management measures.

Addressing concerns about tumor formation, Gupta reassured that due to stem cells' strict self-regulatory mechanisms, the risk of stem cells developing into cancer cells is minimal and may even reduce the risk of cancer development. I let it happen.

Regarding the use of exosomes, Mr. Gupta expressed enthusiasm about their therapeutic potential. He emphasized the importance of exosomes in signal transduction and reducing inflammation, and noted the compatibility of exosomes across different patients with minimal immune detection. Mr. Gupta also praised Helene Clinic's rigorous purification and testing methods for exosomes, which ensure quality and efficacy. He discussed the possibility of combining mesenchymal stem cell therapy with exosomes and envisioned a synergistic effect that could enhance therapeutic outcomes.

Overall, the esteemed professor at the University of Cambridge praised the Helene Clinic's cutting-edge technology and innovative approach, confirming that it is at the forefront of stem cell therapy research and application.